Belantamab Mafodotin (GSK2857916) Drives Immunogenic Cell Death and Immune-mediated Antitumor Responses In VivoGSK2857916 Drives ICD and Adaptive Antitumor Responses

Overview of attention for article published in Molecular Cancer Therapeutics, July 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (79th percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

twitter: 9 X users

patent: 1 patent

Citations

dimensions_citation: 50 Dimensions

Readers on

mendeley: 35 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

ANTIBODY BINDING TO BCMA AND USE THEREOF

Application WO-2023104100-A1

World Intellectual Property Organisation (WIPO)